NeuroPace Balance Sheet Health
Financial Health criteria checks 5/6
NeuroPace has a total shareholder equity of $14.3M and total debt of $58.0M, which brings its debt-to-equity ratio to 404.7%. Its total assets and total liabilities are $98.9M and $84.5M respectively.
Key information
404.7%
Debt to equity ratio
US$58.04m
Debt
Interest coverage ratio | n/a |
Cash | US$58.95m |
Equity | US$14.34m |
Total liabilities | US$84.51m |
Total assets | US$98.85m |
Recent financial health updates
Recent updates
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Financial Position Analysis
Short Term Liabilities: NPCE's short term assets ($84.3M) exceed its short term liabilities ($13.1M).
Long Term Liabilities: NPCE's short term assets ($84.3M) exceed its long term liabilities ($71.4M).
Debt to Equity History and Analysis
Debt Level: NPCE has more cash than its total debt.
Reducing Debt: Insufficient data to determine if NPCE's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NPCE has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NPCE has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 2.1% each year